Avandryl study: Comparing the efficacy & safety of fixed-dose rosiglitazone/glimepiride combination therapy to glimepiride monotherapy & rosigilitazone monotherapy in drug naive subjects with type 2 d
- Narayan, Kam, (Primary Chief Investigator (PCI))
- Gerstman, Murray, (Chief Investigator (CI))
Project: Research